Feedback PLC Directorate Change (8078E)
14 Februar 2018 - 8:00AM
UK Regulatory
TIDMFDBK
RNS Number : 8078E
Feedback PLC
14 February 2018
This announcement contains inside information as stipulated
under the Market Abuse Regulation (EU) No 596/2014 (MAR).
14 February 2018
Feedback plc
("Feedback" or the "Company")
Directorate change
Appointment of new Chief Executive Officer to drive growth
strategy
Cambridge, UK - 14 February 2018: Feedback plc ("Feedback" or
the "Company") (AIM: FDBK), the specialist medical imaging
technology company, announces that it has appointed David Crabb as
Chief Executive Officer and a director of Feedback with immediate
effect. This appointment will underpin the execution of the
Company's growth strategy following the first CE marked release of
TexRAD(R) ; the Company's patented quantitative image texture
analysis technology for diagnostic radiological scans.
Mr Crabb brings 20 years of experience as an effective business
leader to Feedback. Most recently he was Chief Executive Officer of
Cambridge Online Systems, a major software company providing
services to UK and international customers, which was acquired by
the global IT group Columbus in December 2016. Under Mr Crabb's
management in 2011, Cambridge Online Systems delivered strong
growth from a loss-making organisation to one with top-quartile
financial results and was voted as one of the "Sunday Times Top 100
Companies to work for" in two consecutive years. Previously, Mr
Crabb held director-level roles in medium-sized technology and
outsourced solutions companies with revenues from GBP50 million to
over GBP1 billion, responsible for business optimisation, sales and
marketing and workforce leadership.
Dr Alastair Riddell, Chairman of Feedback plc, said: "Since the
acquisition of Cambridge Computed Imaging Ltd and TexRAD Limited in
2014, Feedback plc has developed a strong reputation in the field
of medical imaging and is privileged to be working with over 40 of
the world's leading research institutions. We recognise that a
small, multi-disciplinary team has its limitations, which resulted
in some operational delays over the past 12 months, so I am
delighted that Feedback has attracted a highly experienced
executive to complement the strong technical and regulatory
expertise within the Company. Under David's leadership, we are
well-positioned to leverage our pioneering technology to create
evidence-based imaging software, arming clinicians with innovative
tools to improve patient outcomes."
David Crabb, Chief Executive Officer of Feedback plc, commented:
"I am impressed with the platform technologies and domain expertise
at Feedback. The medical imaging and diagnostics market is a
dynamic, fast-paced environment where disruptive technologies are
very much needed. The opportunity is not without its challenges, as
with all pioneering development, but as a small, ambitious company
which has experienced both acquisition and organic growth, there is
significant opportunity to optimise and expand Feedback's
operations. Our long-term vision is to lead global innovation in
quantitative medical imaging analysis - I believe we have strong
foundations to position ourselves at the forefront of this
important field and I am looking forward to refining our strategy
over the coming months."
Regulatory Disclosures
In accordance with Rule 17 and Schedule 2(g) of the AIM Rules
for Companies, David James Crabb, aged 50 is, or has been within
the last five years, a director or partner in the following
companies and partnerships:
Current directorships Past directorships and
and partnerships partnerships held within
the last five years
David Crabb Consulting Cambridge Online Systems
Limited Limited
There is no other information required to be disclosed under the
AIM Rules for Companies.
Notes to editors
About Feedback plc
Feedback plc is a specialist medical imaging technology company.
It develops software and systems that provide innovative techniques
and improved workflows for practitioners involved in medical
research and treating patients. TexRAD(R) , the Company's patented
quantitative image texture analysis technology, has the potential
to assist clinicians in diagnosis, prognosis and treatment of
patients with cancer and is currently installed in over 40 of the
world's leading research institutions across Europe, North America,
Asia and Australasia. The Cadran platform provides a suite of
medical imaging tools for decision support. The Cadran range
includes the picture archiving communication system (PACS) to
provide decision support for scan analysis, diagnostic workstations
which provide secure remote access to view scans on demand, and
products to securely share and transport patient data. Visit
www.fbk.com.
For further information, please contact:
Feedback plc Tel: 01954 718072
David Crabb, Chief Executive IR@fbk.com
Officer
Lara Mott, Investor Relations
Allenby Capital Limited (Nominated Tel: 020 3328
Adviser and Joint Broker) 5656
David Worlidge / Asha Chotai
Northland Capital Partners Ltd Tel: 020 3861
(Joint Broker) 6625
David Hignell / John Howes
Peterhouse Corporate Finance Tel: 020 7469
Ltd (Joint Broker) 0936
Lucy Williams / Duncan Vasey
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOATJMJTMBABTBP
(END) Dow Jones Newswires
February 14, 2018 02:00 ET (07:00 GMT)
Feedback (LSE:FDBK)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Feedback (LSE:FDBK)
Historical Stock Chart
Von Jul 2023 bis Jul 2024